TY - JOUR
KW - Adolescent
KW - Adult
KW - Aftercare
KW - Delayed-Action Preparations/therapeutic use
KW - Humans
KW - Injections, Intramuscular
KW - Naltrexone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Patient Discharge
KW - Young Adult
KW - Extended-release naltrexone
KW - Naltrexone
KW - opioid use disorder
KW - treatment
AU - S. G. Mitchell
AU - L. B. Monico
AU - J. Gryczynski
AU - M. J. Fishman
AU - K. E. O'Grady
AU - R. P. Schwartz
A1 - 
AD - Friends Research Institute, 1040 Park Avenue, Suite, 103 Baltimore, MD, USA. Electronic address: smitchell@friendsresearch.org.; Friends Research Institute, 1040 Park Avenue, Suite, 103 Baltimore, MD, USA. Electronic address: lmonico@friendsresearch.org.; Friends Research Institute, 1040 Park Avenue, Suite, 103 Baltimore, MD, USA. Electronic address: jgryczynski@friendsresearch.org.; Mountain Manor Treatment Center, 3800 Frederick Avenue, Baltimore 21229, MD, USA.; Department of Psychology, University of Maryland, College Park, College Park, MD, USA. Electronic address: ogrady@umd.edu.; Friends Research Institute, 1040 Park Avenue, Suite, 103 Baltimore, MD, USA. Electronic address: rschwartz@friendsresearch.org.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.jsat.2021.108407
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - . Published by Elsevier Inc
PY - 2021
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108407
T1 - Extended-release naltrexone for youth with opioid use disorder
T2 - Journal of substance abuse treatment
TI - Extended-release naltrexone for youth with opioid use disorder
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34118699
U3 - 10.1016/j.jsat.2021.108407
VL - 130
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2021
Y2 - Nov
ER -